A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevitySven J. van der Lee, Estrella Morenas‐Rodríguez, The GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group et al.|Acta Neuropathologica|2019Cited by 132
A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer's Disease, Dementia with Lewy-Bodies and Frontotemporal Dementia, and Increases the Likelihood of LongevitySven J. van der Lee, Heinz Wiendl, Olivia J. Conway et al.|SSRN Electronic Journal|2018Cited by 26